E
Erhan Onalan
Researcher at Fırat University
Publications - 34
Citations - 115
Erhan Onalan is an academic researcher from Fırat University. The author has contributed to research in topics: Diabetes mellitus & Medicine. The author has an hindex of 4, co-authored 25 publications receiving 43 citations.
Papers
More filters
Journal ArticleDOI
Knowledge, attitude and anxiety of medical students about the current COVID-19 outbreak in Turkey
TL;DR: Fakultedeki her iki ogrenciden birine sistematik ornekleme yontemi kullanilarak bir anket formu whats-up uzerinden gonderilmistir yontem: Kesitsel arastirma 07-14 Nisan tarihleri arasinda, tip fakultesi ogrencilerine uygulanan online anketformlari ile gerceklest
Journal ArticleDOI
The relationship between monocyte to high-density lipoprotein cholesterol ratio and diabetic nephropathy.
TL;DR: The results suggest that an elevated MHR can be a biomarker for diabetic nephropathy, allowing the detection of diabetic neephropathy with simple and inexpensive laboratory tests.
Journal ArticleDOI
Can hematological parameters in type 2 diabetes predict microvascular complication development
TL;DR: Hmatologic parameters such as hematocrit, MPV, NLR, and PLR, which can be obtained through a simple complete blood count, may be utilized as cost-effective predictors of diabetic microvascular complications.
Neutrophil and platelet to lymphocyte ratio in patients with hypothyroid Hashimoto's thyroiditis.
Erhan Onalan,Emir Dönder +1 more
TL;DR: As values that can be measured with an inexpensive and easily accessible routine hemogram, PLR and NLR can serve as practical and valuable markers at the clinical course or the severity of the disease and other diseases that are autoimmune and progress with chronic inflammation.
Journal ArticleDOI
Low serum levels of meteorin-like/subfatin: an indicator of diabetes mellitus and insulin resistance?
Erhan Onalan,Cundullah Cavli,Yusuf Dogan,Ebru Önalan,Nevzat Gözel,Ilay Buran,Burkay Yakar,Emir Dönder +7 more
TL;DR: Serum levels of subfatin show a gradual decrease from healthy individuals to more advanced stages of diabetes, suggesting that it can serve as a useful marker in the prediabetic period in individuals with risk factors for diabetes.